Cargando…

Direct Control of Brown Adipose Tissue Thermogenesis by Central Nervous System Glucagon-Like Peptide-1 Receptor Signaling

We studied interscapular brown adipose tissue (iBAT) activity in wild-type (WT) and glucagon-like peptide 1 receptor (GLP-1R)–deficient mice after the administration of the proglucagon-derived peptides (PGDPs) glucagon-like peptide (GLP-1), glucagon (GCG), and oxyntomodulin (OXM) directly into the b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lockie, Sarah H., Heppner, Kristy M., Chaudhary, Nilika, Chabenne, Joseph R., Morgan, Donald A., Veyrat-Durebex, Christelle, Ananthakrishnan, Gayathri, Rohner-Jeanrenaud, Françoise, Drucker, Daniel J., DiMarchi, Richard, Rahmouni, Kamal, Oldfield, Brian J., Tschöp, Matthias H., Perez-Tilve, Diego
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478556/ https://www.ncbi.nlm.nih.gov/pubmed/22933116 http://dx.doi.org/10.2337/db11-1556

Ejemplares similares

A glucagon analog chemically stabilized for immediate treatment of life-threatening hypoglycemia()
por: Chabenne, Joseph, et al.
Publicado: (2014)

Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance
por: Poher, Anne-Laure, et al.
Publicado: (2015)

Central Glucocorticoid Administration Promotes Weight Gain and Increased 11β-Hydroxysteroid Dehydrogenase Type 1 Expression in White Adipose Tissue
por: Veyrat-Durebex, Christelle, et al.
Publicado: (2012)

Improved Leptin Sensitivity as a Potential Candidate Responsible for the Spontaneous Food Restriction of the Lou/C Rat
por: Veyrat-Durebex, Christelle, et al.
Publicado: (2013)

Preserving of Postnatal Leptin Signaling in Obesity-Resistant Lou/C Rats following a Perinatal High-Fat Diet
por: Poher, Anne-Laure, et al.
Publicado: (2016)

Brown adipose tissue thermogenesis in the resistance to and reversal of obesity: A potential new mechanism contributing to the metabolic benefits of proglucagon-derived peptides
por: Lockie, Sarah H, et al.
Publicado: (2013)

Peripheral, but Not Central, CB1 Antagonism Provides Food Intake–Independent Metabolic Benefits in Diet-Induced Obese Rats
por: Nogueiras, Ruben, et al.
Publicado: (2008)

Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes
por: Capozzi, Megan E, et al.
Publicado: (2018)

Glucagon, GLP-1 and Thermogenesis
por: González-García, Ismael, et al.
Publicado: (2019)

GLP-1/glucagon receptor co-agonism for treatment of obesity
por: Sánchez-Garrido, Miguel A., et al.
Publicado: (2017)

A Role for Adipose Tissue De Novo Lipogenesis in Glucose Homeostasis During Catch-up Growth: A Randle Cycle Favoring Fat Storage
por: Marcelino, Helena, et al.
Publicado: (2013)

Fibroblast Growth Factor 21 Mediates Specific Glucagon Actions
por: Habegger, Kirk M., et al.
Publicado: (2013)

Mechanisms of the Anti-Obesity Effects of Oxytocin in Diet-Induced Obese Rats
por: Deblon, Nicolas, et al.
Publicado: (2011)

Both Acyl and Des-Acyl Ghrelin Regulate Adiposity and Glucose Metabolism via Central Nervous System Ghrelin Receptors
por: Heppner, Kristy M., et al.
Publicado: (2014)

Glucagon-like peptide 1 (GLP-1)
por: Müller, T.D., et al.
Publicado: (2019)

Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism
por: Mroz, Piotr A., et al.
Publicado: (2018)

Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice
por: Jall, Sigrid, et al.
Publicado: (2017)

Outstanding Scientific Achievement Award Lecture 2011: Defeating Diabesity: The Case for Personalized Combinatorial Therapies
por: Tschöp, Matthias H., et al.
Publicado: (2012)

GLP-1 based therapeutics: simultaneously combating T2DM and obesity
por: Heppner, Kristy M., et al.
Publicado: (2015)

A Facile Procedure for One-Pot Stable Conjugation of Two Proglucagon Cysteine-Containing Peptide Analogs
por: He, Rongjun, et al.
Publicado: (2021)

High-fat-diet-induced obesity causes an inflammatory and tumor-promoting microenvironment in the rat kidney
por: Stemmer, Kerstin, et al.
Publicado: (2012)

Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice
por: Knerr, Patrick J., et al.
Publicado: (2022)

Deletion of the glucagon receptor gene before and after experimental diabetes reveals differential protection from hyperglycemia
por: Rivero-Gutierrez, Belen, et al.
Publicado: (2018)

Hypothalamic Glucagon Receptors Regulate Feeding in Mice
por: Cunningham, Stephen E, et al.
Publicado: (2021)

Fibroblast activation protein (FAP) as a novel metabolic target
por: Sánchez-Garrido, Miguel Angel, et al.
Publicado: (2016)

Glucagon Peptide Family and Adipose Tissue: Not that Intimate, just Acquaintances
por: Perez-Tilve, Diego
Publicado: (2020)

GLP-1R Agonism Enhances Adjustable Gastric Banding in Diet-Induced Obese Rats
por: Habegger, Kirk M., et al.
Publicado: (2013)

GLP-1R Responsiveness Predicts Individual Gastric Bypass Efficacy on Glucose Tolerance in Rats
por: Habegger, Kirk M., et al.
Publicado: (2014)

Countering impaired glucose homeostasis during catch-up growth with essential polyunsaturated fatty acids: is there a major role for improved insulin sensitivity?
por: Calonne, Julie, et al.
Publicado: (2021)

Anti-obesity drug discovery: advances and challenges
por: Müller, Timo D., et al.
Publicado: (2021)

Chronic Oxytocin Administration as a Treatment Against Impaired Leptin Signaling or Leptin Resistance in Obesity
por: Altirriba, Jordi, et al.
Publicado: (2015)

Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis
por: Tiano, Joseph P., et al.
Publicado: (2015)

OR28-5 Bile Acid Sequestration Accelerates Glucagon Receptor-Mediated Body Weight Loss in Obese Mice
por: Kim, Teayoun, et al.
Publicado: (2019)

Ketogenic Diet Impairs FGF21 Signaling and Promotes Differential Inflammatory Responses in the Liver and White Adipose Tissue
por: Asrih, Mohamed, et al.
Publicado: (2015)

Gαs regulates Glucagon-Like Peptide 1 Receptor-mediated cyclic AMP generation at Rab5 endosomal compartment
por: Girada, Shravan Babu, et al.
Publicado: (2017)

Oxytocin Administration Alleviates Acute but Not Chronic Leptin Resistance of Diet-Induced Obese Mice
por: Labyb, Mehdi, et al.
Publicado: (2018)

SAT-655 Bile Acid Sequestration Synergistically Accelerates Glucagon Receptor-Stimulated Body Weight Loss in Diet-Induced Obese Mice
por: Kim, Teayoun, et al.
Publicado: (2020)

Vertical Sleeve Gastrectomy Is Effective in Two Genetic Mouse Models of Glucagon-Like Peptide 1 Receptor Deficiency
por: Wilson-Pérez, Hilary E., et al.
Publicado: (2013)

Ablation of Ghrelin O-Acyltransferase Does Not Improve Glucose Intolerance or Body Adiposity in Mice on a Leptin-Deficient ob/ob Background
por: Kirchner, Henriette, et al.
Publicado: (2013)

“Let's Stay Together”; GIP and GLP-1 dual agonism in the treatment of metabolic disease
por: DiMarchi, Richard D.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6od91pmija4gmo7t0802bcdpdj